{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-120646","form_type":"8-K","ticker":null,"cik":"0001554859","company_name":"Semler Scientific, Inc.","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.726400+00:00","generated_at":"2026-05-16T13:21:12.843836+00:00","sec_items":["2.05","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Semler cuts headcount 37%, reports $1.2M severance; provides Strive merger updates","bullets":["Headcount reduction of ~37% approved; expected to reduce quarterly opex by $0.7-1.1M from Jan 2026.","Severance costs of ~$1.2M (one-time termination benefits) to be paid Dec 2025/Jan 2026.","$1.6M time-based cash retention program for non-exec employees during merger pendency and integration.","Strive entered agreement allowing conversion of Class B to Class A common stock and filed $500M at-the-market preferred stock offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-120646","json":"https://secwatch.observer/filing/0001104659-25-120646.json","markdown":"https://secwatch.observer/filing/0001104659-25-120646.md","text":"https://secwatch.observer/filing/0001104659-25-120646.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/tm2533379d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:21:12.843836+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"10ac705dcc3baa0cbf90098763d27dd36c6d44cb","claim":"Semler Scientific, Inc. announced a restructuring with charges of approximately $1.2 million consisting of one-time termination benefits (approximately 37%).","evidence_excerpt":"the headcount reduction, which are expected to be realized beginning in January 2026. Semler Scientific currently estimates that it will incur severance costs of approximately $1.2 million consisting of one-time termination benefits, which are expected to be paid in December 2025 and January 2026. The charges Semler Scientific expects to incur in connection with","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001193125-26-031987","ticker":"IOBTQ","company_name":"IO Biotech, Inc.","filed_at":"2026-01-30T23:59:59+00:00","headline":"IO Biotech explores strategic alternatives, cuts workforce, CMO departs, hires Raymond James","event_type":"other_material","sec_items":["2.05","5.02","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-031987","json":"https://secwatch.observer/filing/0001193125-26-031987.json","markdown":"https://secwatch.observer/filing/0001193125-26-031987.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865494/000119312526031987/0001193125-26-031987-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865494/000119312526031987/d13704d8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"the headcount reduction, which are expected to be realized beginning in\nJanuary 2026. Semler Scientific currently estimates that it will incur severance costs of approximately $1.2 million consisting of\none-time termination benefits, which are expected to be paid in December 2025 and January 2026. The charges Semler Scientific expects\nto incur in connection with","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","comparable_excerpt":"As part of previously announced efforts by IO Biotech, Inc. (the “Company”) to reduce the Company’s operating expenses while the Company explores a range of strategic alternatives, the Board of Directors of the Company approved on January 21, 2026, a restructuring and workforce reduction plan (the “Plan”) which is expected to result in a significant reduction of the Company’s workforce globally. In connection with the implementation of the Plan, the Company expects to incur one-time charges and cash expenditures in a range of approximately $2.4 million to $2.6 million, primarily related to employee wages and severance payments, healthcare continuation, earned vacation time and related termination costs.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1865494/000119312526031987/0001193125-26-031987-index.htm"}},{"accession":"0001084765-26-000011","ticker":"RGP","company_name":"RESOURCES CONNECTION, INC.","filed_at":"2026-01-28T23:59:59+00:00","headline":"Resources Connection announces workforce reduction and $0.07 quarterly dividend","event_type":"other_material","sec_items":["2.05","8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001084765-26-000011","json":"https://secwatch.observer/filing/0001084765-26-000011.json","markdown":"https://secwatch.observer/filing/0001084765-26-000011.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1084765/000108476526000011/0001084765-26-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1084765/000108476526000011/rgp-20260122.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"the headcount reduction, which are expected to be realized beginning in\nJanuary 2026. Semler Scientific currently estimates that it will incur severance costs of approximately $1.2 million consisting of\none-time termination benefits, which are expected to be paid in December 2025 and January 2026. The charges Semler Scientific expects\nto incur in connection with","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","comparable_excerpt":"efficiencies and streamlined operations. We expect the reduction in force to result in annual cost savings of $6 million to $8 million. Restructuring charges of approximately $3 million are expected to be recognized in the third and fourth quarters of fiscal 2026 and primarily consist of cash charges for employee termination benefits. We expect the workforce","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1084765/000108476526000011/0001084765-26-000011-index.htm"}},{"accession":"0001213900-26-052921","ticker":"AIRE","company_name":"reAlpha Tech Corp.","filed_at":"2026-05-06T23:59:59+00:00","headline":"reAlpha cuts workforce 25%, targets $2M annual savings in restructuring","event_type":"other_material","sec_items":["2.05","7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-052921","json":"https://secwatch.observer/filing/0001213900-26-052921.json","markdown":"https://secwatch.observer/filing/0001213900-26-052921.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026052921/0001213900-26-052921-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026052921/ea0289539-8k_realpha.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"the headcount reduction, which are expected to be realized beginning in\nJanuary 2026. Semler Scientific currently estimates that it will incur severance costs of approximately $1.2 million consisting of\none-time termination benefits, which are expected to be paid in December 2025 and January 2026. The charges Semler Scientific expects\nto incur in connection with","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","comparable_excerpt":"Plan as well as savings related\nto certain restricted stock units lapsing over the next twelve months. The Company estimates that\nit will incur pre-tax charges in the range of $0.14 million to $0.20 million in connection with the Plan, consisting of approximately\n$0.10 to $0.15 in future cash-based expenditures associated with severance and benefit payments and","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026052921/0001213900-26-052921-index.htm"}},{"accession":"0001193125-26-192362","ticker":"AUTL","company_name":"Autolus Therapeutics plc","filed_at":"2026-04-29T23:59:59+00:00","headline":"Autolus cuts workforce 13%; expects $8M restructuring charge, $15M annualized savings","event_type":"other_material","sec_items":["2.05","7.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-192362","json":"https://secwatch.observer/filing/0001193125-26-192362.json","markdown":"https://secwatch.observer/filing/0001193125-26-192362.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730463/000119312526192362/0001193125-26-192362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730463/000119312526192362/d113906d8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"the headcount reduction, which are expected to be realized beginning in\nJanuary 2026. Semler Scientific currently estimates that it will incur severance costs of approximately $1.2 million consisting of\none-time termination benefits, which are expected to be paid in December 2025 and January 2026. The charges Semler Scientific expects\nto incur in connection with","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","comparable_excerpt":"Item 2.05 Costs Associated with Exit or Disposal Activities. On April 29, 2026, Autolus Therapeutics plc (the “Company”) announced its Board of Directors approved a plan to improve operational efficiency and reduce operating expenses. This plan will implement a reduction in force whereby the Company will eliminate approximately 13% of the Company’s workforce, inclusive of employee-related actions that began in the second half of 2025. The Company anticipates that it will complete the implementation of the plan by the third quarter of 2026. Affected employees will be offered separation benefits, including severance payments and, where applicable, temporary healthcare coverage assistance. The Company estimates that it will incur total expenses relating to the realignment of approximately $8 million, consisting of severance and termination-related costs. The Company expects to record a significant portion of these charges in the first half of 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1730463/000119312526192362/0001193125-26-192362-index.htm"}},{"accession":"0001104659-26-049837","ticker":"IAC","company_name":"IAC Inc.","filed_at":"2026-04-28T23:59:59+00:00","headline":"IAC announces name change to 'People Incorporated', restructuring with $40M cost savings, and C-suite changes","event_type":"other_material","sec_items":["2.02","7.01","2.05","5.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-049837","json":"https://secwatch.observer/filing/0001104659-26-049837.json","markdown":"https://secwatch.observer/filing/0001104659-26-049837.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800227/000110465926049837/0001104659-26-049837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800227/000110465926049837/tm2612831d1_8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"the headcount reduction, which are expected to be realized beginning in\nJanuary 2026. Semler Scientific currently estimates that it will incur severance costs of approximately $1.2 million consisting of\none-time termination benefits, which are expected to be paid in December 2025 and January 2026. The charges Semler Scientific expects\nto incur in connection with","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","comparable_excerpt":"Ahead of its name change to \"People Incorporated\" which is expected to occur with the release of Q2 2026 earnings in August, the Company has initiated a plan to consolidate its corporate functions with those of its People Inc. business (\" People \"), through a reduction in workforce, technology integrations, and other cost-saving measures over the coming quarters (the \" Plan \"). The Plan is expected to generate annual run-rate cost savings of approximately $40 million. The Plan is expected to be completed by Q1 of 2027. The Company expects to incur approximately $14 million in severance and related expenses, $48 million in non-cash stock-based compensation expense and $0.5 million to $1 million in other costs related to the Plan.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800227/000110465926049837/0001104659-26-049837-index.htm"}},{"accession":"0001193125-26-155861","ticker":"SNAP","company_name":"Snap Inc","filed_at":"2026-04-15T23:59:59+00:00","headline":"Snap reports Q1 rev ~$1.53B (+12% YoY), adj EBITDA ~$233M; cuts 16% of staff (~1,000 jobs)","event_type":"other_material","sec_items":["2.02","2.05","7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-155861","json":"https://secwatch.observer/filing/0001193125-26-155861.json","markdown":"https://secwatch.observer/filing/0001193125-26-155861.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1564408/000119312526155861/0001193125-26-155861-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1564408/000119312526155861/d36756d8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"the headcount reduction, which are expected to be realized beginning in\nJanuary 2026. Semler Scientific currently estimates that it will incur severance costs of approximately $1.2 million consisting of\none-time termination benefits, which are expected to be paid in December 2025 and January 2026. The charges Semler Scientific expects\nto incur in connection with","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","comparable_excerpt":"increased operational efficiencies to accelerate our path toward net-income profitability. As a result, we currently estimate that we will incur pre-tax charges in the range of $95 million to $130 million, primarily consisting of severance and related costs, contract termination costs, and other impairment charges, of which $75 million to $100 million are expected","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1564408/000119312526155861/0001193125-26-155861-index.htm"}},{"accession":"0001193125-26-149752","ticker":"CARS","company_name":"Cars.com Inc.","filed_at":"2026-04-09T23:59:59+00:00","headline":"Cars.com cuts 11% of workforce, expects $8.5-9M charges; reaffirms FY guidance","event_type":"other_material","sec_items":["2.02","2.05","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-149752","json":"https://secwatch.observer/filing/0001193125-26-149752.json","markdown":"https://secwatch.observer/filing/0001193125-26-149752.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1683606/000119312526149752/0001193125-26-149752-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1683606/000119312526149752/cars-20260406.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"the headcount reduction, which are expected to be realized beginning in\nJanuary 2026. Semler Scientific currently estimates that it will incur severance costs of approximately $1.2 million consisting of\none-time termination benefits, which are expected to be paid in December 2025 and January 2026. The charges Semler Scientific expects\nto incur in connection with","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","comparable_excerpt":"On April 9, 2026, the Company also announced a cost reduction program that includes a reduction in the Company’s workforce of approximately 11% of its full-time roles, including certain management roles and two executive roles. In connection with this workforce reduction, the Company expects to incur aggregate charges of approximately $8.5-$9 million, consisting primarily of employee-related costs, including severance, benefits, and other related expenses.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1683606/000119312526149752/0001193125-26-149752-index.htm"}},{"accession":"0001193125-26-143876","ticker":"STIM","company_name":"Neuronetics, Inc.","filed_at":"2026-04-06T23:59:59+00:00","headline":"Neuronetics announces CFO resignation, 5% workforce reduction, and former CEO consulting deal","event_type":"other_material","sec_items":["1.01","2.05","5.02","7.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-143876","json":"https://secwatch.observer/filing/0001193125-26-143876.json","markdown":"https://secwatch.observer/filing/0001193125-26-143876.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1227636/000119312526143876/0001193125-26-143876-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1227636/000119312526143876/d107138d8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"the headcount reduction, which are expected to be realized beginning in\nJanuary 2026. Semler Scientific currently estimates that it will incur severance costs of approximately $1.2 million consisting of\none-time termination benefits, which are expected to be paid in December 2025 and January 2026. The charges Semler Scientific expects\nto incur in connection with","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1554859/000110465925120646/0001104659-25-120646-index.htm","comparable_excerpt":"On April 2, 2026, the Company initiated a workforce reduction, which it expects to be completed by mid-year 2026, that will impact up to 5% of its employees. The reduction is part of a broader effort to optimize the Company’s cost structure. The Company expects to incur restructuring charges of approximately $0.2 million, primarily for severance and related costs, in the second quarter of 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1227636/000119312526143876/0001193125-26-143876-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}